Anzeige
Mehr »
Login
Sonntag, 22.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU8Q | ISIN: CA74141E1043 | Ticker-Symbol: 18H
Frankfurt
20.12.24
08:04 Uhr
0,014 Euro
+0,004
+33,33 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREVECEUTICAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
PREVECEUTICAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0100,02521.12.

Aktuelle News zur PREVECEUTICAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiPreveCeutical Medical Inc.: PreveCeutical Announces Change of Auditors289Vancouver, British Columbia--(Newsfile Corp. - December 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that the Company has...
► Artikel lesen
09.12.Preveceutical Medical Inc: Preveceutical's BioGene appoints Lawson as director3
PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln
09.12.PreveCeutical Medical Inc.: BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors307Vancouver, British Columbia--(Newsfile Corp. - December 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
05.12.Preveceutical Medical Inc: Preveceutical's BioGene adds Ticho to advisory board4
05.12.PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho684Vancouver, British Columbia--(Newsfile Corp. - December 5, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
04.12.Preveceutical Medical Inc: Preveceutical's BioGene appoints advisory board member3
04.12.PreveCeutical Medical Inc.: BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board171Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
02.12.Preveceutical Medical Inc: Preveceutical unit appoints Glover independent director2
02.12.PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors159Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
25.11.Preveceutical Medical Inc: Preveceutical's BioGene appoints Sampath as director1
25.11.PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors191Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
21.11.Preveceutical Medical Inc: Preveceutical's BioGene adds Dellbegovic as adviser2
21.11.PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board176Vancouver, British Columbia--(Newsfile Corp. - November 21, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
18.11.Preveceutical Medical Inc: Preveceutical names Olofsson chief scientific officer2
18.11.PreveCeutical Medical Inc.: PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer136Vancouver, British Columbia--(Newsfile Corp. - November 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
15.11.Preveceutical Medical Inc: Preveceutical Medical closes IP asset sale to BioGene3
15.11.PreveCeutical Medical Inc.: PreveCeutical Announces Closing of BioGene Therapeutics Transaction359Vancouver, British Columbia--(Newsfile Corp. - November 15, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
13.11.Preveceutical Medical Inc: Preveceutical appoints Georgieva as BioGene president3
13.11.PreveCeutical Medical Inc.: PreveCeutical's Subsidiary, BioGene Therapeutics, Appoints President200Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
30.10.Preveceutical Medical Inc: Preveceutical to sell IP to BioGene for $1.35M (U.S.)3
Seite:  Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1